Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-12, Stock:ABBV, The news for the past five days is as follows:
2020-06-05: NEWS1: Pharma Giant AbbVie Enters Ring With A Potential Coronavirus Treatment.NEWS2: AbbVie Enters the Race to Develop New COVID-19 Treatments.NEWS3: Biotech Stock To Watch: Why This Leader Could Be Poised For Another Run.NEWS4: The Market Timing Secrets No One Talks About - June 05, 2020.NEWS5: The Zacks Analyst Blog Highlights: AbbVie, Amkor Technology, Calix, The Hain Celestial Group and Acacia Communications.NEWS6: Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals.NEWS7: The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid.NEWS8: AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Announce Collaboration to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19.
2020-06-08: NEWS1: AbbVie (ABBV) Gains But Lags Market: What You Should Know.NEWS2: Vertex CEO Provided Best Value for Investors.NEWS3: Merck's Antibiotic Recarbrio Gets FDA Nod for New Indication.NEWS4: AbbVie (ABBV) Joins Race for Developing Coronavirus Treatment.NEWS5: Silgan, Canada Goose, Sempra Energy, Fortinet and Abbvie highlighted as Zacks Bull and Bear of the Day.NEWS6: AbbVie’s Rinvoq Beats Bristol-Myers’ Orencia In New Rheumatoid Arthritis DatA.
2020-06-09: NEWS1: Roche, Johnson & Johnson Top R&D Spenders in 2019.NEWS2: Tuesday Morning Market Highlights.NEWS3: AbbVie Is Concocting a Formula for a Breakout.
2020-06-10: NEWS1: This Biotech Just Hit Pay Dirt On A Potential $3 Billion Deal With AbbVie.NEWS2: AbbVie's Humira on Steroids (Literally) Treats Rheumatoid Arthritis Better Than the Original.NEWS3: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS4: Wednesday Morning Market Highlights.NEWS5: AbbVie Signs $3.9 Billion Oncology Deal with Genmab.NEWS6: AbbVie Can Withstand Humira’s Decline With New Drugs.NEWS7: AbbVie and Genmab Ink $4 Billion Cancer-Treatment Pact.NEWS8: ESG Investing Trend to Stay Strong Post Pandemic: 5 Top Picks.NEWS9: Novel Antibody Drug Conjugate ABBV-3373 Shows Improvement in Disease Activity in Phase 2a Study of Patients with Rheumatoid Arthritis.NEWS10: Genmab Shares Rise 5% In Pre-Market On Oncology Partnership With AbbVie.NEWS11: Genmab's stock surges after drug development deal with AbbView valued at up to nearly $4 billion.NEWS12: AbbVie and Genmab Announce Broad Oncology Collaboration.
2020-06-11: NEWS1: AbbVie Inks Deal With Genmab, Announces ADC Candidate Data.NEWS2: Top Ranked Value Stocks to Buy for June 11th.NEWS3: AbbVie (ABBV) Hits 52-Week High, Can the Run Continue?.NEWS4: 3 Wins for AbbVie in 3 Days Provide 3 More Good Reasons to Buy the Pharma Stock.

Answer: Rise